Insulet (PODD) Stock: Buy, Sell, or Hold?
PODD - Insulet Corporation
$148.72
0.59 (0.40%)
▲
5d:
+5.4%
30d:
+9.53%
90d:
-9.87%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 04, 2026
11d
Get Alerted When PODD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: PODD shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: PODD shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$328.68
Based on 11.4% avg growth
INTRINSIC VALUE TODAY
$204.08
27.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PODD is currently trading at $148.72, which is considered extended relative to its 30-day fair value range of $133.20 to $140.39. From a valuation perspective, the stock is trading at a discount (Forward PE: 19.2) compared to its historical average (27.3). Remarkably, the market is currently pricing in an annual earnings decline of 11.1% over the next few years. This pessimistic expectation contrasts with the company's recent 328.6% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, PODD is in a downtrend. The price is approaching resistance at $148.96. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: PODD scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $167.17 (+12.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PODD is in a downtrend. The price is approaching resistance at $148.96. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: PODD scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $167.17 (+12.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$133.20 -
$140.39
Company Quality Score
37/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
21.4%
Protect Your Profits
Holding PODD? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+5.9% above its trading range)
- BEARISH: Weak technical setup (30/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($167.17)
- WARNING: Composite score 37/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$133.20 -
$140.39
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$133.58
Resistance Level
$148.96
Current Trend
Downtrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.18
Wall Street Target
$167.17
(+12.9%)
Revenue Growth (YoY)
23.5%
Earnings Growth (YoY)
328.6%
Profit Margin
12.3%
Valuation Discount vs History
-11.1% cheaper
PE vs Historical
19.2 vs 27.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-11.1%
(market-implied from PE analysis)
1-Year Target
$133.31
(-10%)
2-Year Target
$119.98
(-19%)
3-Year Target
$107.98
(-27%)
3-Yr Target (if PE normalizes)
(PE: 19→27)
$153.69
(+4%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 18.7%)
$256.32
(+73%)
Base:
(SPY PE: 19.2, Growth: 18.7%)
$247.55
(+67%)
Bear:
(PE: 16.3, Growth: 18.7%)
$210.42
(+42%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (27x PE), but valuation improves significantly next year (19x PE) as earnings recover.
Trailing PE: 26.72 | Current EPS (TTM): $5.31
Bull Case
$227.00
(+53%)
Analyst growth 45.4%, PE expands to 29.4
Base Case
$206.36
(+39%)
Market implied 45.4%, PE stable at 26.7
Bear Case
$96.49
(-35%)
Severe decline -20.0%, PE contracts to 22.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 19.2 to 27.3
Stabilization Target:
$210.82
(+42.3%)
PE Expansion Potential:
+42.3%
Share & Embed Analysis
Last updated: October 23, 2026 1:16 PM ET
Data refreshes hourly during market hours. Next update: 2:16 PM
Data refreshes hourly during market hours. Next update: 2:16 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PODD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
EW
Edwards Lifesciences Corp |
STRONG BUY
29 analysts |
$102 | 58 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$96 | 46 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$121 | 52 HOLD |
|
BSX
Boston Scientific Corp |
STRONG BUY
31 analysts |
$59 | 41 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
29 analysts |
$363 | 37 SELL |
Advanced PODD Option Strategies
Professional options setups generated by AI based on today's PODD price and gamma walls.
